Correlation Between Sonnet Biotherapeutics and Elevation Oncology
Can any of the company-specific risk be diversified away by investing in both Sonnet Biotherapeutics and Elevation Oncology at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Sonnet Biotherapeutics and Elevation Oncology into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Sonnet Biotherapeutics Holdings and Elevation Oncology, you can compare the effects of market volatilities on Sonnet Biotherapeutics and Elevation Oncology and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Sonnet Biotherapeutics with a short position of Elevation Oncology. Check out your portfolio center. Please also check ongoing floating volatility patterns of Sonnet Biotherapeutics and Elevation Oncology.
Diversification Opportunities for Sonnet Biotherapeutics and Elevation Oncology
-0.43 | Correlation Coefficient |
Very good diversification
The 3 months correlation between Sonnet and Elevation is -0.43. Overlapping area represents the amount of risk that can be diversified away by holding Sonnet Biotherapeutics Holding and Elevation Oncology in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Elevation Oncology and Sonnet Biotherapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Sonnet Biotherapeutics Holdings are associated (or correlated) with Elevation Oncology. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Elevation Oncology has no effect on the direction of Sonnet Biotherapeutics i.e., Sonnet Biotherapeutics and Elevation Oncology go up and down completely randomly.
Pair Corralation between Sonnet Biotherapeutics and Elevation Oncology
Given the investment horizon of 90 days Sonnet Biotherapeutics is expected to generate 10.55 times less return on investment than Elevation Oncology. But when comparing it to its historical volatility, Sonnet Biotherapeutics Holdings is 1.0 times less risky than Elevation Oncology. It trades about 0.01 of its potential returns per unit of risk. Elevation Oncology is currently generating about 0.06 of returns per unit of risk over similar time horizon. If you would invest 66.00 in Elevation Oncology on November 4, 2024 and sell it today you would earn a total of 3.00 from holding Elevation Oncology or generate 4.55% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Very Weak |
| Accuracy | 100.0% |
| Values | Daily Returns |
Sonnet Biotherapeutics Holding vs. Elevation Oncology
Performance |
| Timeline |
| Sonnet Biotherapeutics |
| Elevation Oncology |
Sonnet Biotherapeutics and Elevation Oncology Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Sonnet Biotherapeutics and Elevation Oncology
The main advantage of trading using opposite Sonnet Biotherapeutics and Elevation Oncology positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Sonnet Biotherapeutics position performs unexpectedly, Elevation Oncology can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Elevation Oncology will offset losses from the drop in Elevation Oncology's long position.| Sonnet Biotherapeutics vs. ZyVersa Therapeutics | Sonnet Biotherapeutics vs. Allarity Therapeutics | Sonnet Biotherapeutics vs. Immix Biopharma | Sonnet Biotherapeutics vs. Cns Pharmaceuticals |
| Elevation Oncology vs. Ocean Biomedical | Elevation Oncology vs. Zura Bio Limited | Elevation Oncology vs. Enveric Biosciences | Elevation Oncology vs. Hepion Pharmaceuticals |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Stock Tickers module to use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites.
Other Complementary Tools
| Volatility Analysis Get historical volatility and risk analysis based on latest market data | |
| Sync Your Broker Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors. | |
| Price Exposure Probability Analyze equity upside and downside potential for a given time horizon across multiple markets | |
| CEOs Directory Screen CEOs from public companies around the world | |
| Companies Directory Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals |